search
Back to results

Effects of Sucralose on Glucose Metabolism (Sucralose)

Primary Purpose

Glucose Metabolism Disorders

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Sucralose
Sponsored by
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Glucose Metabolism Disorders focused on measuring sucralose, insulin sensitivity, beta-cell response, appetite regulating hormone

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • both genders
  • age between 18 and 55 years
  • body mass index ≥18.5 and <25 kg/m2
  • low consumption of non-nutritive sweeteners

Exclusion Criteria:

  • diabetes or glucose intolerance
  • consumption of medications affecting insulin sensitivity (metformin, steroids, hormone replacement therapy, contraceptives)
  • intestinal disease such as malabsorption or previous intestinal resection
  • history of bariatric surgery
  • pregnancy or lactation
  • weight loss greater than 5% in the previous month

Sites / Locations

  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Sucralose

Control

Arm Description

Ingestion of 15% of the ADI of sucralose daily during two weeks

Absence of sucralose ingestion

Outcomes

Primary Outcome Measures

Insulin sensitivity
Insulin sensitivity and pancreatic response estimated with the minimal model using a frequently sampled IV glucose tolerance test

Secondary Outcome Measures

Glucagon like peptide (GLP-1) change
Change in fasting GLP-1 after sucralose ingestion
Ghrelin change
Change in fasting ghrelin after sucralose ingestion
Tyrosine-tyrosine peptide (PYY) change
Change in fasting PYY after sucralose ingestion
Leptin change
Change in fasting leptin after sucralose ingestion

Full Information

First Posted
October 15, 2015
Last Updated
November 8, 2017
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
search

1. Study Identification

Unique Protocol Identification Number
NCT02589002
Brief Title
Effects of Sucralose on Glucose Metabolism
Acronym
Sucralose
Official Title
Effects of Sucralose on Insulin Sensitivity, Pancreatic Response and Appetite Regulating Hormones
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
July 2015 (undefined)
Primary Completion Date
March 2017 (Actual)
Study Completion Date
June 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In this study the effects of sucralose on insulin sensitivity, beta-cell response and appetite regulating hormones will be evaluated.
Detailed Description
The consumption of non-nutritive sweeteners has a high prevalence. The effect of non-nutritive sweeteners in both beta-cell function and insulin resistance it is unknown. Previous studies performed in animal models and humans with diverse characteristics have shown variable effects of different non-nutritive sweeteners in variables related to glucose metabolism. Due to the high consumption of non-nutritive sweeteners it is relevant to know its effect in beta cell-function and insulin sensitivity. In this study the effects of sucralose, a non-nutritive sweetener that is highly consumed in the population, on insulin sensitivity and beta-cell function will be evaluated. 54 participants with normal glucose tolerance, normal weight, and without chronic diseases with a low consumption of non-nutritive sweeteners will be included. The participants will be randomly assigned to consume sucralose or to a control group. During the first visit an oral glucose tolerance test with 75 g of glucose will be performed. Fasting and 2-hour glucose will be measured in order to rule-out diabetes, abnormal fasting glucose, or glucose intolerance. During the second visit a three-hour IV glucose tolerance test will be performed administering 0.3 g/kg of glucose and insulin 0.03 U/kg. Samples will be taken following the minimal model described by Bergman. After this visit, the group assigned to receive sucralose will ingest 15% of the adequate daily intake (ADI) of sucralose and the control group will abstain of any non-nutritive sweetener consumption during 14 days. At the end of this period a third visit to repeat the IV glucose tolerance test will be performed. Samples will be analyzed measuring glucose and insulin concentrations to evaluate acute insulin response (AIR), glucose effectiveness (SG), first phase pancreatic response (ф1), and second phase pancreatic response (ф2). In addition, hormones involved in appetite and satiety (leptin, ghrelin, and peptide tyrosine tyrosine) will be quantified at the beginning and end of the intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glucose Metabolism Disorders
Keywords
sucralose, insulin sensitivity, beta-cell response, appetite regulating hormone

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
66 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sucralose
Arm Type
Experimental
Arm Description
Ingestion of 15% of the ADI of sucralose daily during two weeks
Arm Title
Control
Arm Type
No Intervention
Arm Description
Absence of sucralose ingestion
Intervention Type
Other
Intervention Name(s)
Sucralose
Other Intervention Name(s)
Non-nutritive sweetener
Primary Outcome Measure Information:
Title
Insulin sensitivity
Description
Insulin sensitivity and pancreatic response estimated with the minimal model using a frequently sampled IV glucose tolerance test
Time Frame
Two weeks
Secondary Outcome Measure Information:
Title
Glucagon like peptide (GLP-1) change
Description
Change in fasting GLP-1 after sucralose ingestion
Time Frame
Two weeks
Title
Ghrelin change
Description
Change in fasting ghrelin after sucralose ingestion
Time Frame
Two weeks
Title
Tyrosine-tyrosine peptide (PYY) change
Description
Change in fasting PYY after sucralose ingestion
Time Frame
Two weeks
Title
Leptin change
Description
Change in fasting leptin after sucralose ingestion
Time Frame
Two weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: both genders age between 18 and 55 years body mass index ≥18.5 and <25 kg/m2 low consumption of non-nutritive sweeteners Exclusion Criteria: diabetes or glucose intolerance consumption of medications affecting insulin sensitivity (metformin, steroids, hormone replacement therapy, contraceptives) intestinal disease such as malabsorption or previous intestinal resection history of bariatric surgery pregnancy or lactation weight loss greater than 5% in the previous month
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paloma Almeda-Valdes, MD, PhD
Organizational Affiliation
Attending Physician
Official's Role
Principal Investigator
Facility Information:
Facility Name
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
City
Mexico City
State/Province
Distrito Federal
ZIP/Postal Code
14080
Country
Mexico

12. IPD Sharing Statement

Citations:
PubMed Identifier
25231862
Citation
Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.
Results Reference
background
PubMed Identifier
22410815
Citation
Brown RJ, Walter M, Rother KI. Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care. 2012 May;35(5):959-64. doi: 10.2337/dc11-2424. Epub 2012 Mar 12.
Results Reference
background
PubMed Identifier
23633524
Citation
Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care. 2013 Sep;36(9):2530-5. doi: 10.2337/dc12-2221. Epub 2013 Apr 30.
Results Reference
result
PubMed Identifier
30535090
Citation
Romo-Romo A, Aguilar-Salinas CA, Brito-Cordova GX, Gomez-Diaz RA, Almeda-Valdes P. Sucralose decreases insulin sensitivity in healthy subjects: a randomized controlled trial. Am J Clin Nutr. 2018 Sep 1;108(3):485-491. doi: 10.1093/ajcn/nqy152.
Results Reference
derived

Learn more about this trial

Effects of Sucralose on Glucose Metabolism

We'll reach out to this number within 24 hrs